Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study

J Allergy Clin Immunol Pract. 2021 Jun;9(6):2482-2485.e2. doi: 10.1016/j.jaip.2021.02.044. Epub 2021 Mar 4.
No abstract available

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Allergic Agents* / therapeutic use
  • Chronic Disease
  • Chronic Urticaria*
  • Humans
  • Longitudinal Studies
  • Omalizumab / therapeutic use
  • Treatment Outcome
  • Urticaria* / drug therapy

Substances

  • Anti-Allergic Agents
  • Omalizumab